Balloon pulmonary angioplasty in patients with CTEPH

lt;p>

Francesco Saia is a Senior Interventional Cardiologist at the University Hospital of Bologna,  and  an expert on coronary and structural heart interventions. He is  author or co-author of more than 280 publications in indexed, peer-reviewed medical journals and several book chapters; and co-editor of several medical books. In addition, he serves on the Editorial Boards of the journals: Eurointervention, Catheterization and Cardiovascular Interventions, British Journal of Cardiology, and Giornale Italiano di Cardiologia.

Hiromi Matsubara is Deputy Director of the National Hospital Organization Okayama Medical Center, the institute with the most experience in Balloon Pulmonary Angioplasty worldwide. His research interests have focused on clinical and physiological aspects of pulmonary hypertension. He started balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension in 2004 and experienced about 3,000 procedures of BPA in more than 500 patients during past 17 years. He has made Department of Cardiology at Okayama Medical Center as the largest BPA center in Japan.

 1 Epidemiology and pathophysiology of CTEPH.- 2 Diagnosis of CTEPH.- 3 Pulmonary Thromboendoaterectomy: the only cure for CTEPH.- 4 Medical treatment of CTEPH.- 5 Development of Balloon Pulmonary Angioplasty in CTEPH: an historical perspective.- 6 Balloon pulmonary angioplasty in CTEPH: modern technique.- 7 Balloon pulmonary angioplasty: clinical outcomes.- 8 Lesion classification in CTEPH with an interventional perspective.- 9 Advanced non-invasive imaging to guide BPA.- 10 Use of intravascular imaging and pressure guide during BPA.- 11 Balloon pulmonary angioplasty in proximal lesions.- 12 Metrics for success of balloon pulmonary angioplasty in CTEPH.- 13 Management of complications during balloon pulmonary angioplasty in CTEPH.- 14 BPA in CTEPH: next steps?.- 15 CTEPH and chronic thromboembolic disease (CTED): clinical and interventional perspective.